Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020.
Adolescent
Adult
Aged
Aged, 80 and over
COVID-19
COVID-19 Nucleic Acid Testing
Child
Child, Preschool
Contact Tracing
Coronavirus
Coronavirus Infections
/ epidemiology
Female
Hospitalization
/ statistics & numerical data
Humans
Incidence
Infant
Infant, Newborn
Italy
/ epidemiology
Male
Middle Aged
Pandemics
Physical Distancing
Pneumonia, Viral
/ epidemiology
Public Health
SARS-CoV-2
Young Adult
COVID-19
Italy
SARS-CoV-2
coronavirus
pandemic
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
BackgroundVeneto was one of the Italian regions hit hardest by the early phase of the coronavirus disease (COVID-19) pandemic.AimThis paper describes the public health response and epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the Veneto Region from 21 February to 2 April 2020.MethodsInformation on the public health response was collected from regional health authorities' official sources. Epidemiological data were extracted from a web-based regional surveillance system. The epidemic curve was represented by date of testing. Characteristics of hospitalised COVID-19 cases were described and compared to those never admitted to hospital. Age- and sex-stratified case-fatality ratios (CFRs) were calculated.ResultsKey elements of the regional public health response were thorough case-finding and contact tracing, home care for non-severe cases, creation of dedicated COVID-19 healthcare facilities and activation of sub-intensive care units for non-invasive ventilation. As at 2 April 2020, 91,345 individuals were tested for SARS-CoV-2 and 10,457 (11.4%) were positive. Testing and attack rates were 18.6 per 1,000 and 213.2 per 100,000 population, respectively. The epidemic peaked around 20 to 24 March, with case numbers declining thereafter. Hospitalised cases (n = 3,623; 34.6%) were older and more frequently male compared with never-hospitalised cases. The CFR was 5.6% overall, and was higher among males and people > 60 years of age.ConclusionIn the Veneto Region, the strict social distancing measures imposed by the Italian government were supported by thorough case finding and contact tracing, as well as well-defined roles for different levels of care.
Identifiants
pubmed: 33243356
doi: 10.2807/1560-7917.ES.2020.25.47.2000548
pmc: PMC7693165
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Science. 2020 May 8;368(6491):
pubmed: 32234805
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2341-2345
pubmed: 32425461
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Med Virol. 2020 Jun;92(6):639-644
pubmed: 32141619
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet Infect Dis. 2020 Jul;20(7):756-757
pubmed: 32251637
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
J Microbiol Immunol Infect. 2020 Jun;53(3):404-412
pubmed: 32173241
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
BMJ. 2020 Mar 16;368:m1065
pubmed: 32179517
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265005
Lancet Infect Dis. 2020 Apr;20(4):410-411
pubmed: 32087116
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404